Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus

Hippocampus

Volumn 17, Issue 8, 2007, Pages 679-691

  Carlson, Erik S ^a,b   Stead, John D H ^c   Neal, Charles R ^d   Petryk, Anna ^a,b   Georgieff, Michael K ^a,b,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c CARLETON UNIVERSITY   (Canada)

^d UNIVERSITY OF HAWAII   (United States)

^e MMC 39 Mayo   (United States)

Author keywords

Dendrite development; Developmental disorders; Microarray; Neonatal; Synaptogenesis

Indexed keywords

BRAIN PROTEIN; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; IRON; MAMMALIAN TARGET OF RAPAMYCIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE (CALCIUM,CALMODULIN) IIALPHA; SYNAPTOBREVIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN FUNCTION; BRAIN METABOLISM; CELL GROWTH; COGNITION; DENDRITE; ENERGY METABOLISM; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON DEFICIENCY; IRON METABOLISM; IRON TRANSPORT; MALE; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; PERINATAL CARE; POLYMERASE CHAIN REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; CELL SIZE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; IRON; IRON METABOLISM DISORDERS; MALE; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548075903     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20307     Document Type: Article

References (73)

1. Algarin C, Peirano P, Garrido M, Pizarro F, Lozoff B. 2003. Iron deficiency anemia in infancy: Long-lasting effects on auditory and visual system functioning. Pediatr Res 53:217-223.
2. Bear MF, Malenka RC. 1994. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 4:389-399.
3. Beard JL, Connor JR. 2003. Iron status and neural functioning. Annu Rev Nutr 23:41-58.
4. Bing DH, Almeda S, Isliker H, Lahav J, Hynes RO. 1982. Fibronectin binds to the C1q component of Complement. Proc Natl Acad Sci USA 79:4198-201.
5. Brenner C, Deplus R, Didelot C, Loriot A, Vire E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, Pelicci PG, Amati B, Kouzarides T, de Launoit Y, Di Croce L, Fuks F. 2005. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 24:336-346.
6. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr. 2003. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4:147-158.
7. Cai C, Li H, Rivera C, Keinanen K. 2006. Interaction between SAP97 and PSD-95, two maguk proteins involved in synaptic trafficking of AMPA receptors. J Biol Chem 281:4267-4273.
8. Charych EI, Akum BF, Goldberg JS, Jornsten RJ, Rongo C, Zheng JQ, Firestein BL. 2006. Activity-independent regulation of dendrite patterning by postsynaptic density protein PSD-95. J Neurosci 26:10164-10176.
9. Chen Y, Abraham DJ, Shi-Wen X, Pearson JD, Black CM, Lyons KM, Leask A. 2004. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell 15:5635-5646.
10. Choi J, Chen J, Schreiber SL, Clardy J. 1996. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 273:239-242.
11. Clardy SL, Wang X, Zhao W, Liu W, Chase GA, Beard JL, Felt BT, Connor JR. 2006. Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm 71:1-18.
12. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K. 2006. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442:307-311.
13. Collins JF, Franck CA, Kowdley KV, Ghishan FK. 2005. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am J Physiol Gastrointest Liver Physiol 288:G964-G971.
14. de Ungria M, Rao R, Wobken JD, Luciana M, Nelson CA, Georgieff MK. 2000. Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatr Res 48:169-176.
15. Dwyer BE, Takeda A, Zhu X, Perry G, Smith MA. 2005. Ferric cycle activity and alzheimer disease. Curr Neurovasc Res 2:261-267.
16. Edinger AL, Thompson CB. 2002. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 13:2276-2288.
17. Eisenstein RS. 2000. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 20:627-62.
18. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA. 2002. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10:995-1005.
19. Felt BT, Lozoff B. 1996. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr 126:693-701.
20. Fukuda M. 2003. Distinct rab binding specificity of Rim1, Rim2, rabphilin, and Noc2. identification of a critical determinant of Rab3A/Rab27A recognition by Rim2. J Biol Chem 278:15373-15380.
21. Georgieff MK, Petry CE, Wobken JD, Oyer CE. 1996. Liver and brain iron deficiency in newborn infants with bilateral renal agenesis (Potter's syndrome). Pediatr Pathol 16:509-519.
22. Gong R, Park CS, Abbassi NR, Tang SJ. 2006. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem 281:18802-18815.
23. Hada T, Hagiya H, Suzuki H, Arakawa T, Nakamura M, Matsuda S, Yoshimoto T, Yamamoto S, Azekawa T, Morita Y. 1994. Arachidonate 12-lipoxygenase of rat pineal glands: Catalytic properties and primary structure deduced from its cDNA. Biochim Biophys Acta 1211:221-228.
24. Hall A, Hakansson K, Mason RW, Grubb A, Abrahamson M. 1995. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferrin residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 270:5115-5121.
25. Hentze MW, Muckenthaler MU, Andrews NC. 2004. Balancing acts: Molecular control of mammalian iron metabolism. Cell 117:285-297.
26. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Muller U. 2004. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J 23:4106-4115.
27. Inoki K, Li Y, Xu T, Guan KL. 2003. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829-1834.
28. Jorgenson LA, Wobken JD, Georgieff MK. 2003. Perinatal iron deficiency alters apical dendritic growth in hippocampal CA1 pyramidal neurons. Dev Neurosci 25:412-420.
29. Jorgenson LA, Sun M, O'Connor M, Georgieff MK. 2005. Fetal iron deficiency disrupts the maturation of synaptic function and efficacy in area CA1 of the developing rat hippocampus. Hippocampus 15:1094-1102.
30. Koibuchi N, Chin WW. 2000. Thyroid hormone action and brain development. Trends Endocrinol Metab 11:123-128.
31. Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K. 1998. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol 154:511-521.
32. Lozoff B, Georgieff MK. 2006. Iron deficiency and brain development. Semin Pediatr Neurol 13:158-165.
33. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW. 2000. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 105:E51.
34. Lu M, Grove EA, Miller RJ. 2002. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99:7090-7095.
35. Malinow R, Schulman H, Tsien RW. 1989. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245:862-866.
36. Mayford M, Wang J, Kandel ER, O'Dell TJ. 1995. CaMKII regulates the frequency-response function of hippocampal synapses for the production of both LTD, LTP. Cell 81:891-904.
37. McEchron MD, Cheng AY, Liu H, Connor JR, Gilmartin MR. 2005. Perinatal nutritional iron deficiency permanently impairs hippocampus-dependent trace fear conditioning in rats. Nutr Neurosci 8:195-206.
38. McPherson JP, Tamblyn L, Elia A, Migon E, Shehabeldin A, Matysiak-Zablocki E, Lemmers B, Salmena L, Hakem A, Fish J, Kassam F, Squire J, Bruneau BG, Hande MP, Hakem R. 2004. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J 23:3677-3688.
39. Miller S, Yasuda M, Coats JK, Jones Y, Martone ME, Mayford M. 2002. Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron 36:507-519.
40. Mitchelmore C, Buchmann-Moller S, Rask L, West MJ, Troncoso JC, Jensen NA. 2004. NDRG2: A novel Alzheimer's disease associated protein. Neurobiol Dis 16:48-58.
41. Miyake S, Yamashita T, Taniguchi M, Tamatani M, Sato K, Tohyama M. 2002. Identification and characterization of a novel mitochondrial tricarboxylate carrier. Biochem Biophys Res Commun 295:463-468.
42. Mochida S, Sheng ZH, Baker C, Kobayashi H, Catterall WA. 1996. Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron 17:781-788.
43. Moos T, Oates PS, Morgan EH. 2001. Expression of transferrin mRNA in rat oligodendrocytes is iron-independent and changes with increasing age. Nutr Neurosci 4:15-23.
44. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L. 2006. Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer's disease. Neuron 51:703-714.
45. Murray JT, Campbell DG, Morrice N, Auld GC, Shpiro N, Marquez R, Peggie M, Bain J, Bloomberg GB, Grahammer F, Lang F, Wullf P, Kuhl D, Cohen P. 2004. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J 384:477-488.
46. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, Dang CV. 2006. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 26:2373-2386.
47. Okabe T, Nakamura T, Nishimura YN, Kohu K, Ohwada S, Morishita Y, Akiyama T. 2003. RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in the beta-catenin-N-cadherin and N-methyl- D-aspartate receptor signaling. J Biol Chem 278:9920-9927.
48. Okahara F, Ikawa H, Kanaho Y, Maehama T. 2004. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem 279:45300-45303.
49. Pang H, Bartlam M, Zeng Q, Miyatake H, Hisano T, Mild K, Wong LL, Gao GF, Rao Z. 2004. Crystal structure of human pirin: An iron-binding nuclear protein and transcription cofactor. J Biol Chem 279:1491-1498.
50. Peng PL, Zhong X, Tu W, Soundarapandian MM, Molner P, Zhu D, Lau L, Liu S, Liu F, Lu Y. 2006. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 49:719-733.
51. Petry CD, Eaton MA, Wobken JD, Mills MM, Johnson DE, Georgieff MK. 1992. Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothers. J Pediatr 121:109-114.
52. Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA, Trojanowski JQ, Lee VM. 2004. 12/15-lipoxygenase is increased in Alzheimer's disease: Possible involvement in brain oxidative stress. Am J Pathol 164:1655-1662.
53. Puig S, Askeland E, Thiele DJ. 2005. Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 120:99-110.
54. Pujol F, Kitabgi P, Boudin H. 2005. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci 118:1071-1080.
55. Rao R, Tkac I, Townsend EL, Gruetter R, Georgieff MK. 2003. Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. J Nutr 133:3215-3221.
56. Roncagliolo M, Garrido M, Walter T, Peirano P, Lozoff B. 1998. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: Delayed maturation of auditory brainstem responses. Am J Clin Nutr 68:683-690.
57. Rongo C, Kaplan JM. 1999. CaMKII regulates the density of central glutamatergic synapses in vivo. Nature 402:195-199.
58. Rossner MJ, Dorr J, Gass P, Schwab MH, Nave KA. 1997. SHARPs: Mammalian enhancer-of-split- and hairy-related proteins coupled to neuronal stimulation. Mol Cell Neurosci 10:460-475.
59. Schmitt JM, Wayman GA, Nozaki N, Soderling TR. 2004. Calcium activation of ERK mediated by calmodulin kinase I. J Biol Chem 279:24064-24072.
60. Schratt GM, Nigh EA, Chen WG, Hu L, Greenberg ME. 2004. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neurosci 24:7366-7377.
61. Siddappa AJ, Rao RB, Wobken JD, Leibold EA, Connor JR, Georgieff MK. 2002. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res 68:761-775.
62. Siddappa AJ, Rao RB, Wobken JD, Casperson K, Leibold EA, Connor JR, Georgieff MK. 2003. Iron deficiency alters iron regulatory protein and iron transport protein expression in the perinatal rat brain. Pediatr Res 53:800-807.
63. Siddappa AM, Georgieff MK, Wewerka S, Worwa C, Nelson CA, Deregnier RA. 2004. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res 55:1034-1041.
64. Silva AJ, Paylor R, Wehner JM, Tonegawa S. 1992. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257:206-211.
65. Smith MA, Harris PLR, Sayre LM, Perry G. 1997. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868.
66. Sofer A, Lei K, Johannessen CM, Ellisen LW. 2005. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25:5834-5845.
67. Stead JD, Neal C, Meng F, Wang Y, Evans S, Vazquez DM, Watson SJ, Akil H. 2006. Transcriptional profiling of the developing rat brain reveals that the most dramatic regional differentiation in gene expression occurs postpartum. J Neurosci 26:345-353.
68. Vickers CA, Stephens B, Bowen J, Arbuthnott GW, Grant SG, Ingham CA. 2006. Neurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95). Brain Res 1090:89-98.
69. Wu GY, Cline HT. 1998. Stabilization of dendritic arbor structure in vivo by CaMKII. Science 279:222-226.
70. Wu KJ, Polack A, Dalla-Favera R. 1999. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676-679.
71. Youdim MB, Sills MA, Heydorn WE, Creed GJ, Jacobowitz DM. 1986. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens. J Neurochem 47:794-799.
72. Zambrano N, Minopoli G, de Candia P, Russo T. 1998. The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273:20128-20133.
73. Zou DJ, Cline HT. 1999. Postsynaptic calcium/calmodulin-dependent protein kinase II is required to limit elaboration of presynaptic and postsynaptic neuronal arbors. J Neurosci 19:8909-8918.